Advertisement
Advertisement
May 26, 2021
Koya Medical’s Dayspring Compression Device Cleared by FDA for Lower Extremities
May 26, 2021—Koya Medical announced that it has received FDA 510(k) clearance for its Dayspring active compression therapy system for the treatment of lymphedema and venous diseases that impact lymphatic flow in lower extremities. Koya previously received FDA clearance for Dayspring for upper extremities in June 2020. Koya is currently conducting a limited pilot launch of Dayspring for upper extremities.
According to the company, patients treated with Dayspring receive standard of care active compression therapy with a mobility-enabling wearable device designed with real-life demands in mind.
The Dayspring system’s compression therapy option is designed to enable movement, mobility, and personalized care that is unavailable with traditional compression therapy. The Dayspring system includes a low-profile active garment made of soft, breathable mesh using Koya’s proprietary Flexframe technology; a smart, rechargeable, hand-held controller that can be worn on a lanyard; and a mobile app that allows users or their clinicians to program custom treatment options, stated the company.
Advertisement
Advertisement
